RPTX - Repare Therapeutics GAAP EPS of -$0.45 beats by $0.43 revenue of $2.16M misses by $4.15M
2023-11-09 07:50:27 ET
More on Repare Therapeutics
- Repare: Potential Of Camonsertib With Several Shots On Goal
- Repare Therapeutics: A Compelling Bet On Synthetic Lethality
- Seeking Alpha’s Quant Rating on Repare Therapeutics
- Historical earnings data for Repare Therapeutics
- Financial information for Repare Therapeutics
For further details see:
Repare Therapeutics GAAP EPS of -$0.45 beats by $0.43, revenue of $2.16M misses by $4.15M